ScreenerHero

TTX Tetratherix Ltd.

ASX · AU · Healthcare · Biotechnology · tetratherix.com
—Mkt Cap: —P/E: —

Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical devices in the areas of bone regeneration, tissue spacing…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.87BUSDP/E 29.6
MRNA
Moderna, Inc.
$94.42BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$81.99BUSDP/E 19.1
ARGX
argenx SE
$53.47BUSDP/E 32.5
ARGX
argenx SE
$53.22BUSDP/E 31.6
UCB
UCB SA
$44.02BUSDP/E 17.8
ONC
BeOne Medicines AG
$42.56BUSDP/E 66.4
RVMD
Revolution Medicines, Inc.
$40.57BUSD
RPRX
Royalty Pharma plc
$34.45BUSDP/E 30.4
ALNY
Alnylam Pharmaceuticals, Inc.
$31.32BUSDP/E 39.3
ROIV
Roivant Sciences Ltd.
$24.59BUSD
GMAB
Genmab A/S
$23.32BUSDP/E 31.7
GMAB
Genmab A/S
$23.26BUSDP/E 29.8
INCY
Incyte Corporation
$22.96BUSDP/E 14.0
BNTX
BioNTech SE
$22.66BUSD
INSM
Insmed Incorporated
$21.67BUSD
EXEL
Exelixis, Inc.
$15.57BUSDP/E 19.3
ASND
Ascendis Pharma A/S
$14.91BUSDP/E 17.4
JAZZ
Jazz Pharmaceuticals plc
$13.92BUSDP/E 14.7
HALO
Halozyme Therapeutics, Inc.
$13.79BUSDP/E 33.4

Key Statistics

Company
Market Cap—
Enterprise Value205.94M USD
Revenue (TTM)2.67M USD
Gross Profit634.52K USD
Net Income (TTM)-6.44M USD
Revenue/Share0.08 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees25
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU0000400574
Valuation
P/E (Trailing)—
P/E (Forward)-45.96
PEG—
EV/EBITDA-31.65
EV/Revenue77.17
P/S81.90
P/B9.66
EPS (TTM)-0.18
EPS (Forward)-0.13
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin100.00%
Oper. Margin-194.52%
EBITDA Margin-243.82%
Profit Margin-1015.14%
ROE-28.48%
ROA-17.53%
Growth
Revenue Growth313.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.64M USD
CapEx (TTM)3.84M USD
FCF Margin-149.05%
FCF Yield—
Net Debt-16.17M USD
Net Debt/EBITDA2.48
Balance Sheet
Debt/Equity0.34
Current Ratio4.50
Quick Ratio4.40
Book Value/Sh0.62 AUD
Cash/Share0.65 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)6.953 AUD
Target Range5.300 AUD – 8.588 AUD
# Analysts3
Ownership
Shares Out.53.07M
Float14.31M
Insiders72.55%
Institutions2.75%
Technical
SMA 506.589 AUD
SMA 2005.470 AUD
Beta—
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)16.91K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—